Search

everythinglearnresearchcommunity

for

Search:↓

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

More research is needed to find effective treatments for sickle cell disease-related priapism.

"Dutasteride 0.5 mg daily is the most effective treatment for male hair loss."

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

Finasteride and minoxidil together promote hair growth better than either alone.

Finasteride reduces hair growth and is safe for women with excessive hair.

Rats had lasting erectile problems after stopping a certain medication.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride reduces movement issues in Parkinson's disease rats.

Finasteride doesn't affect erections much, but may decrease libido in men.

Finasteride may affect PNMT, causing side effects.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.